Evidence map›Paper›PMID 36803565›Full record

ArticleBMC microbiology2023

Resilience and stability of the CF- intestinal and respiratory microbiome during nutritional and exercise intervention.

Rebecca L Knoll, Víctor Hugo Jarquín-Díaz, Jonas Klopp, Alissa Kemper, Katja Hilbert, Barlo Hillen, Daniel Pfirrmann, Perikles Simon, Viola Bähner, Oliver Nitsche and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Rebecca L Knoll *Pediatric Pulmonology, Allergology and Cystic Fibrosis, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, Germany; Langenbeckstraße 1, 55131, Mainz, Germany.
Víctor Hugo Jarquín-Díaz *Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.
Jonas KloppPediatric Immunology and Infectiology, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, Germany; Langenbeckstraße 1, 55131, Mainz, Germany.
Alissa KemperPediatric Pulmonology, Allergology and Cystic Fibrosis, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, Germany; Langenbeckstraße 1, 55131, Mainz, Germany.
Katja HilbertPediatric Immunology and Infectiology, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, Germany; Langenbeckstraße 1, 55131, Mainz, Germany.
Barlo HillenDepartment of Sports Medicine, Prevention, and Rehabilitation, Faculty of Social Science, Media and Sports, Johannes Gutenberg-University Mainz, Germany; Albert-Schweitzer Str.22, 55128, Mainz, Germany.
Daniel PfirrmannDepartment of Sports Medicine, Prevention, and Rehabilitation, Faculty of Social Science, Media and Sports, Johannes Gutenberg-University Mainz, Germany; Albert-Schweitzer Str.22, 55128, Mainz, Germany.
Perikles SimonDepartment of Sports Medicine, Prevention, and Rehabilitation, Faculty of Social Science, Media and Sports, Johannes Gutenberg-University Mainz, Germany; Albert-Schweitzer Str.22, 55128, Mainz, Germany.
Viola BähnerPediatric Pulmonology, Allergology and Cystic Fibrosis, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, Germany; Langenbeckstraße 1, 55131, Mainz, Germany.
Oliver NitschePediatric Pulmonology, Allergology and Cystic Fibrosis, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, Germany; Langenbeckstraße 1, 55131, Mainz, Germany.
Stephan GehringPediatric Immunology and Infectiology, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, Germany; Langenbeckstraße 1, 55131, Mainz, Germany.
Lajos MarkóExperimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.
Sofia K ForslundExperimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany. sofia.forslund@mdc-berlin.de.
Krystyna PoplawskaPediatric Pulmonology, Allergology and Cystic Fibrosis, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, Germany; Langenbeckstraße 1, 55131, Mainz, Germany. Krystyna.Poplawska@unimedizin-mainz.de.
Johannes Gutenberg University Mainz · DEMax Delbrück Center · DE

Funding

Bundesministerium für Bildung und Forschung F01KI1909AVertex Pharmaceuticals Circle of Care
6 · The paper itself

Abstract

backgroundImpaired respiratory and intestinal microbiome composition is linked to cystic fibrosis lung disease severity. In people with cystic fibrosis (pwCF), regular exercise is recommended to delay disease progression and preserve a stable lung function. An optimal nutritional status is vital for best clinical outcomes. Our study investigated whether regular and monitored exercise and nutritional support promotes CF microbiome health.

methodsA personalized nutrition and exercise program promoted nutritional intake and physical fitness in 18 pwCF for 12 months. Throughout the study, patients performed strength and endurance training monitored by a sports scientist via an internet platform. After three months, food supplementation with Lactobacillus rhamnosus LGG was introduced. Nutritional status and physical fitness were assessed before the study started, after three and nine months. Sputum and stool were collected, and microbial composition was analyzed by 16S rRNA gene sequencing.

resultsSputum and stool microbiome composition remained stable and highly specific to each patient during the study period. Disease-associated pathogens dominated sputum composition. Lung disease severity and recent antibiotic treatment had the highest impact on taxonomic composition in stool and sputum microbiome. Strikingly, the long-term antibiotic treatment burden had only a minor influence.

conclusionDespite the exercise and nutritional intervention, respiratory and intestinal microbiomes proved to be resilient. Dominant pathogens drove the composition and functionality of the microbiome. Further studies are required to understand which therapy could destabilize the dominant disease-associated microbial composition of pwCF.

Indexed as

Cystic FibrosisMicrobiotaAnti-Bacterial AgentsExercise TherapyHumansRNA, Ribosomal, 16SSputumAnti-Bacterial AgentsRNA, Ribosomal, 16SAntibioticsCystic fibrosisGut-lung axisInterventionMicrobiomeNutritionPhysical exercise

Identifiers

PMID36803565
PMCPMC9942320
OpenAlexW4321458386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.